Breaking Nigel Farage Faces Special Election Amidst Financial Scrutiny Ebola Outbreak in Democratic Republic of Congo Surpasses 2,000 Deaths Turkish Parliament Approves Conditional Pardon for Kurdish Militants Amid Peace Initiative Oil Prices Stabilize After Surge Amid Strait of Hormuz Uncertainty Understanding the ‘First-Night Effect’ on Sleep in Unfamiliar Environments

Tuesday August 11, 2026

Reporter

Nuvectis Pharma, Inc.

3Articles Published

5Communities Covered

Published Articles

Press Release

Nuvectis Pharma Reports Second Quarter 2026 Financial Results and Business Highlights

Aug 4

Press Release

Correction: (Title Correction) Nuvectis Announces Marketing Approval of Ciprocopan (NXP100) in China for the Treatment of Patients with PNH Previously Untreated with Complement Inhibitors

Jul 23

Press Release

Ciprocopan (NXP100) Receives Marketing Approval in China for the Treatment of Patients with PNH Previously Untreated with Complement Inhibitors

Jul 23